87 related articles for article (PubMed ID: 12621551)
21. Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2.
Wakisaka N; Murono S; Yoshizaki T; Furukawa M; Pagano JS
Cancer Res; 2002 Nov; 62(21):6337-44. PubMed ID: 12414666
[TBL] [Abstract][Full Text] [Related]
22. [Cross-talk between c-Jun/Ets1 involved in EB virus-encoded latent membrane protein 1 regulates expression of matrix metalloproteinase-9 in nasopharyngeal carcinoma].
Zeng L; Liu YP; Tao YG; Ai MD; Zhao XR; Cao Y
Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):204-8. PubMed ID: 15949416
[TBL] [Abstract][Full Text] [Related]
23. Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma.
Nitta T; Chiba A; Yamamoto N; Yamaoka S
Cell Signal; 2004 Sep; 16(9):1071-81. PubMed ID: 15212767
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma.
Wang C; Ai M; Ren W; Xiao H; Li X; Tang F; Gu H; Yi W; Weng X; Deng X; Cao Y
Chin Med J (Engl); 2003 Jul; 116(7):1022-8. PubMed ID: 12890376
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K.
Mainou BA; Everly DN; Raab-Traub N
Oncogene; 2005 Oct; 24(46):6917-24. PubMed ID: 16007144
[TBL] [Abstract][Full Text] [Related]
26. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E
J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells.
Liu MT; Chen YR; Chen SC; Hu CY; Lin CS; Chang YT; Wang WB; Chen JY
Oncogene; 2004 Apr; 23(14):2531-9. PubMed ID: 14716302
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation.
Floettmann JE; Rowe M
Oncogene; 1997 Oct; 15(15):1851-8. PubMed ID: 9362452
[TBL] [Abstract][Full Text] [Related]
29. [EBV latent membrane protein 1 induces p53 expression via NF-kappa B in nasopharyngeal carcinoma].
Liao W; Tang M; Yin L
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):199-201. PubMed ID: 11783085
[TBL] [Abstract][Full Text] [Related]
30. Modulation of Epstein-Barr virus latent membrane protein 1 activity by intrabodies.
Fang CY; Chiang CY; Pan YR; Tse KP; Chang YS; Chang HY
Intervirology; 2007; 50(4):254-63. PubMed ID: 17460414
[TBL] [Abstract][Full Text] [Related]
31. Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling.
Tsai CL; Li HP; Lu YJ; Hsueh C; Liang Y; Chen CL; Tsao SW; Tse KP; Yu JS; Chang YS
Cancer Res; 2006 Dec; 66(24):11668-76. PubMed ID: 17178861
[TBL] [Abstract][Full Text] [Related]
32. The Epstein-Barr virus encoded latent membrane protein 2A augments signaling from latent membrane protein 1.
Dawson CW; George JH; Blake SM; Longnecker R; Young LS
Virology; 2001 Oct; 289(2):192-207. PubMed ID: 11689042
[TBL] [Abstract][Full Text] [Related]
33. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells.
Yang J; Deng X; Deng L; Gu H; Fan W; Cao Y
J Exp Clin Cancer Res; 2004 Sep; 23(3):495-506. PubMed ID: 15595642
[TBL] [Abstract][Full Text] [Related]
34. HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer.
Lifang Y; Min T; Midan A; Ya C
J Exp Clin Cancer Res; 2008 Sep; 27(1):42. PubMed ID: 18811956
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus-encoded LMP1 promotes cisplatin-induced caspase activation through JNK and NF-kappaB signaling pathways.
Zhang X; Sanmun D; Hu L; Fadeel B; Ernberg I
Biochem Biophys Res Commun; 2007 Aug; 360(1):263-8. PubMed ID: 17586463
[TBL] [Abstract][Full Text] [Related]
36. BS69 negatively regulates the canonical NF-kappaB activation induced by Epstein-Barr virus-derived LMP1.
Ikeda O; Sekine Y; Mizushima A; Oritani K; Yasui T; Fujimuro M; Muromoto R; Nanbo A; Matsuda T
FEBS Lett; 2009 May; 583(10):1567-74. PubMed ID: 19379743
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.
Li HM; Zhuang ZH; Wang Q; Pang JC; Wang XH; Wong HL; Feng HC; Jin DY; Ling MT; Wong YC; Eliopoulos AG; Young LS; Huang DP; Tsao SW
Oncogene; 2004 May; 23(25):4488-94. PubMed ID: 15064751
[TBL] [Abstract][Full Text] [Related]
39. Electroporation-mediated and EBV LMP1-regulated gene therapy in a syngenic mouse tumor model.
Hsieh YH; Wu CJ; Chow KP; Tsai CL; Chang YS
Cancer Gene Ther; 2003 Aug; 10(8):626-36. PubMed ID: 12872144
[TBL] [Abstract][Full Text] [Related]
40. [Effects of two LMP1 variants on resistance of CNE1 cell strain to TGF-beta1].
Huang H; Huang PC
Ai Zheng; 2003 Dec; 22(12):1254-9. PubMed ID: 14693046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
